{"organizations": [], "uuid": "f4aca1ef7860c0e09f9cbeb511fb556c6e6d0952", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/08/10/idUSS8N0Z100020150810", "country": "US", "title": "BRIEF-Novavax Inc says positive top-line data from RSV F-protein vaccine clinical trial in older adults", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "BRIEF-Novavax Inc says positive top-line data from RSV F-protein vaccine clinical trial in older adults | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-08-11T01:55:00.000+03:00", "replies_count": 0, "uuid": "f4aca1ef7860c0e09f9cbeb511fb556c6e6d0952"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/08/10/idUSS8N0Z100020150810", "ord_in_thread": 0, "title": "BRIEF-Novavax Inc says positive top-line data from RSV F-protein vaccine clinical trial in older adults", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Aug 10 Novavax Inc :\n* Positive top-line data from phase 2 RSV F-protein vaccine clinical trial in older adults\n* Trial showed statistically significant vaccine efficacy in prevention of symptomatic rsv disease in older adults\n* RSV F vaccine was well-tolerated and fulfilled co's expectations of primary, secondary and exploratory objectives of trial Source text for Eikon: Further company coverage:", "external_links": [], "published": "2015-08-11T01:55:00.000+03:00", "crawled": "2015-08-11T01:05:24.113+03:00", "highlightTitle": ""}